维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="MARTELLI O"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients显示文摘	Giuseppe Cardillo Francesco Facciolo Andrea O Cavazzana Girolamo Capece Roberto Gasparri Massimo Martelli	2000	The Annals of Thoracic Surgery2000，，6：	2
2	TAILOR:a phase Ⅲ trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR显示文摘	Garassino MC Martelli O Bettini A		0，，：	1
3	Chicken Feath- er Keratin Films Plasticized with Polyethylene Glycol显示文摘	Silvia Maria Martelli Jo? o Borges Laurindo	2012	In ternational Journal of Polymeric Materials2012，，61：	1
4	Rationale for treatment and study design of tailor:a randomized phase Ⅲ trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutat显示文摘	Farina G Longo F Martelli O		0，，02：	1
5	Treatment of patients with small- cell lung cancer: from meta-analyses to clinical practice 显示文摘	Rossi A Martelli O Di Maio M	2013	Cancer Treat Rev2013，39，：	1
6	Phylogeography and genetic ancestry of tigers(Panthera tigris)显示文摘	Luo S J Kim JH Johnson WE van der Walt J Martenson J Yuhki N Miquelle DG Uphyrkina O Goodrich JM Quigley HB Tilson R Brady G Martelli P Subramaniam V McDougal C Hean S Huang SQ Pan W Karanth UK Sunquist M Smith JLD O'Brien SJ		0，，：	1
7	Erlotinib ver- sus docetaxel as second-line treatment of patients with ad- vanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial 显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet 0ncol2013，14，10：	1
8	Erlo- tinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR) :a randomised controlled trial 显示文摘	GARASSINO M C MARTELLI O BROGGINI M	2013	Lancet Oncol2013，14，10：	1
9	TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type(wt) EGFR显示文摘	Garassino M C Martelli O Bettini A	2012	J Clin Oncol2012，，：	1
10	Erlotinib versus do- cetaxel as second - line treatment of patients with advanced non - small - cell lung cancer and wild - type EGFR tumours ( TAI- LOR) :A randomised controlled trial 显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
11	Erlotinih versus do cetaxei as second-line treatment of patients with advanced non- small-cell lung cancer and wild-type EGFR tumours (TAILOR) : a randomised controlled trial显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，98：	1
12	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small- cell lung cancer and wild-type EGFR tumours(TAILOR ) : a randomised controlled trial 显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
13	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial显示文摘	Garassino MC Martelli O Bettini A	2013	Lancet Oncol2013，14，10：	1
14	Erlotinib versus do- cetaxel as second - line treatment of patients with advanced non - small - cell lung cancer and wild - type EGFR tumours (TAI- LOR) : A randomised controlled trial 显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
15	Mechanical Properties, Water Vapor Permeability and Water Affinity of Feather Keratin Films Plasticized with Sorbitol显示文摘	Sílvia Maria Martelli Geovana Rocha Plácido Moore Jo?o Borges Laurindo	2006	Journal of Polymers and the Environment2006，，3：	1
16	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
17	Erlotinib versus docetaxel as second-line treatment of patients with advanced nonsmall-cell lung cancer and wild-type EGFR tumours (TAILOR):a randomised controlled trial显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
18	Erlotinib versus docetaxel as second-line treatment of patients with advanced non- small-cell lung cancer and wild-type EGFR tumours (TAILOR) : a randomised controlled trial显示文摘	Garassino MC Martelli O Broggini M	2013	Lancet Oncol2013，14，10：	1
19	Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma:results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology显示文摘	Stewart RJ Martelli H Oberlin O International Society of Pediatric Oncology	2003	J Clin Oncol2003，21，5：	1
20	Treatment of children with nonmetastatic paratesticular rhabdomyosareoma: results of the Ma- lignant Mesenchymal Tumors Studies ( MMT 84 and MMT 89) of the International Society of Pediatric Ontology 显示文摘	Stewart R J Martelli H Oberlin O	2003	J Clin Oneol2003，21，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示